# Hydroxychloroquine for the Treatment of SARS-CoV2 (COVID 19) : Pharmacokinetic Study

> **NCT04625218** · — · WITHDRAWN · sponsor: **University Hospital, Toulouse**

## Conditions studied

- COVID-19 Pneumonia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04625218
- **Lead sponsor:** University Hospital, Toulouse
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-04-30
- **Primary completion:** 2020-04-30
- **Final completion:** 2020-04-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Hydroxychloroquine is not yet used for the Treatment of SARS-CoV2 (COVID 19)
- **Last updated:** 2023-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04625218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04625218, "Hydroxychloroquine for the Treatment of SARS-CoV2 (COVID 19) : Pharmacokinetic Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04625218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*